Gilead Sciences Voluntarily Pulls Drug for Bladder Cancer After Trial Failure
Gilead Sciences is voluntarily withdrawing cancer drug Trodelvy from the U.S. market as a treatment for advanced cases of urothelial ...
Gilead Sciences is voluntarily withdrawing cancer drug Trodelvy from the U.S. market as a treatment for advanced cases of urothelial ...
The use of a common hormonal intra-uterine device for contraception is linked to a slightly elevated risk of breast cancer, ...
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that ...
Credit: Unsplash/CC0 Public Domain In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one ...
Credit: CC0 Public Domain Cutting-edge research has uncovered how chronic stress disrupts the balance of gut microbiota to speed up ...
Credit: Pixabay/CC0 Public Domain A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore ...
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including ...
Credit: Pixabay/CC0 Public Domain A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed ...
When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew ...
Exact Sciences won Food and Drug Administration approval on Friday for an improved version of a stool-based screening test for ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.